NIH-funded research NIH-funded research

Investigating how changes in brain structure affect cocaine relapse in HIV-infected mice

Official title: Examination of epigenetic spatial architecture in the CNS as a method to understand cocaine relapse in ecoHIV infected mice

Funded at Drexel University · NIH-11031666 · Data updated 2026-11-12

This study is looking at how changes in the brains of mice with ecoHIV might affect their cravings for cocaine, using new imaging technology to take thousands of pictures of their brains, which could help us understand more about drug relapse in people living with HIV.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDrexel University
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 30, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$454,470
NIH project number1R61DA061825-01
Project IDNIH-11031666 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of substance use disorders, particularly those who are also HIV-positive.

Less likely to help

Patients who do not have a history of substance use disorders or are not infected with HIV may not benefit from this research.

What this research studies

This research focuses on understanding the relationship between brain changes and cocaine relapse in mice infected with ecoHIV. By developing a new imaging technique, researchers will capture and analyze over 15,000 images from each animal's brain to study the spatial architecture of histone modifications. This approach utilizes advanced AI and machine learning to identify how these changes in gene expression may influence substance use disorders. The findings could provide insights into the mechanisms behind drug cravings and relapse, particularly in the context of HIV infection.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing relapse in individuals with substance use disorders, especially those living with HIV.

How similar studies have gone: While the specific approach of this research is novel, previous studies have shown that understanding epigenetic changes can provide valuable insights into substance use disorders.

Where this research is happening

  • Drexel University
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Klase, Zachary Alan — Drexel University
  • Study coordinator: Klase, Zachary Alan

Related research

Other NIH-funded projects on the same topics.

  • Social stress and smoking: why disadvantaged young adults struggle to quit

    This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11540695

  • Learning from remission and relapse in lupus (SLE)

    Researchers are studying people with systemic lupus erythematosus who are in long-term remission without steroids or immunosuppressants to understand their immune cells, brain function, and what might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513534

  • Learning from Remission and Relapse in SLE

    A program to study people with systemic lupus erythematosus who are in long-term remission to understand immune and brain signals that might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513533

  • Alternative NF-kB activation after chemotherapy in ovarian cancer

    This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

    NIH research San Diego State University · San Diego, United States · NIH-11473227

  • Predictors of autoimmunity onset and relapse in skin

    A study to understand what biological signals in skin predict when autoimmune diseases start, flare, or worsen in people at risk.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11471389

  • Determinants of TB Control, Relapse, and Reinfection

    A large, multi-year study aims to understand why some people who are treated for TB still have persistent infection or relapse, with the goal of improving prevention and treatment.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11449646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.